Sampo plc
2.10.2026 13:30:00 CEST | Globenewswire | Press release
Sampo plc: Managers’ Transactions (Svensson)
Sampo plc: Managers’ Transactions (Svensson)
Sampo plc, managers’ transactions, 2 October 2026 at 2:30 pm EEST
Sampo plc: Managers’ Transactions (Svensson)
Sampo plc (business code 0142213-3) has received the following notification under Article 19 of the Market Abuse Regulation. Shares have been acquired in accordance with terms and conditions of the long-term incentive scheme 2020:1/2.
____________________________________________
Person subject to the notification requirement
Name: Klas Svensson
Position: Other senior manager
Issuer: Sampo plc
LEI: 743700UF3RL386WIDA22
Notification type: INITIAL NOTIFICATION
Reference number: 175071/9/6
____________________________________________
Transaction date: 2026-09-30
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000552500
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 5,527 Unit price: 8.7456 EUR
Aggregated transactions (1):
Volume: 5,527 Volume weighted average price: 8.7456 EUR
____________________________________________
Transaction date: 2026-10-01
Venue: NASDAQ HELSINKI LTD (XHEL)
Instrument type: SHARE
ISIN: FI4000552500
Nature of transaction: RECEIPT OF A SHARE-BASED INCENTIVE
Transaction details
(1): Volume: 5,498 Unit price: 8.7915 EUR
Aggregated transactions (1):
Volume: 5,498 Volume weighted average price: 8.7915 EUR
____________________________________________
In total, all acquisitions reported above are 11,025 shares.
SAMPO PLC
Mirko Hurmerinta
Interim Head of Investor Relations
tel. +358 10 516 0032
Distribution:
Nasdaq Helsinki
Nasdaq Stockholm
Nasdaq Copenhagen
London Stock Exchange
FIN-FSA
The principal media
www.sampo.com
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Teva Pharmaceutical Industries Ltd2.10.2026 14:00:00 CEST | Press release
Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients
Teva Pharmaceutical Industries Ltd2.10.2026 14:00:00 CEST | Press release
Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome
Nova Capital Management USA LLC2.10.2026 13:00:00 CEST | Press release
Nova Capital Management Acquires BMP Group of Companies and RB Medical from Andrew Industries
Fast Ejendom Danmark2.10.2026 12:31:07 CEST | Pressemeddelelse
Igangsætning af nyt aktietilbagekøbsprogram
IMAGE 72.10.2026 11:30:12 CEST | Press release
Strong and unchanged governance: The Boards of Directors of Cassiopee and DF Holding reaffirm their confidence in Gregory Clerc to calmly continue his mission as Chief Executive Officer of the Castel Group
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom